Food Safety Incidents

Good Manufacturing Practice Violations has been detected in Tea Varieties.

Written by SGS Digicomply Editorial Team | Mar 31, 2026 10:00:00 PM

Incident Report: Good Manufacturing Practice Violations in Tea Varieties

Date of Incident: March 18, 2026

On March 18, 2026, the U.S. Food and Drug Administration reported a significant issue regarding certain tea varieties originating from Mexico. The incident has been classified under the category of Control, specifically highlighting Good Manufacturing Practice (GMP) violations. These violations pertain to inadvertent deviations from established manufacturing protocols, which are crucial for ensuring the safety and quality of food products.

Tea, a widely consumed beverage, is subject to strict regulations to prevent contamination and ensure consumer safety. The identified GMP violations may lead to potential hazards that could affect the integrity of the tea products. It is essential for manufacturers to adhere to established guidelines to mitigate risks associated with food safety.

Consumers are advised to remain vigilant and check for any recalls or safety alerts related to tea varieties from the affected region. It is crucial to prioritize food safety by being informed about the products being consumed. The FDA continues to monitor the situation and will provide updates as more information becomes available.

For further details and guidance, consumers can refer to the official communications from food safety authorities and stay informed about safe food practices.

  • Incident: Good Manufacturing Practice Violations has been detected in Tea Varieties.
  • Date: 2026-03-18
  • Product: Tea Varieties
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Mexico
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Hazard Category: Inadvertent Deviations
  • Source: U.S. Food and Drug Administration